theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Internal Medicine

Pulmonary Infections   

Questions discussed in this category


Do you recommend procalcitonin to help convince other providers to stop antibiotics in patients with pneumonia in whom a non-infectious diagnosis is strongly suspected?
3 Answers available
22136


Papers discussed in this category


Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2022 Sep 10
Use of biomarkers to individualize antimicrobial therapy duration: a narrative review.

The Lancet. Infectious diseases, 2016 Mar 02
Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.

Experimental cell research, 1985 Jan
Cell growth, cell division and cell size homeostasis in Swiss 3T3 cells.

JAMA, 2024 Dec 09
Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis: The ADAPT-Sepsis Randomized Clinical Trial.

Related Topics in Internal Medicine

  • Psychiatry
  • Hematology
  • General Outpatient Psychiatry
  • Infectious Disease
  • General Internal Medicine
  • Cardiology
  • Medical Oncology
  • General Infectious Disease
  • Pulmonology
  • Dermatology

Copyright © 2025 theMednet
All Rights Reserved.